Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Menopause | 38 | 2020 | 86 | 9.790 |
Why?
|
Breast Neoplasms | 34 | 2020 | 666 | 9.000 |
Why?
|
Quality of Life | 37 | 2020 | 816 | 8.440 |
Why?
|
Hot Flashes | 22 | 2020 | 46 | 5.660 |
Why?
|
Women's Health | 27 | 2020 | 226 | 4.520 |
Why?
|
Survivors | 12 | 2018 | 145 | 3.300 |
Why?
|
Acupuncture Therapy | 6 | 2019 | 16 | 2.850 |
Why?
|
Adaptation, Psychological | 8 | 2017 | 125 | 2.740 |
Why?
|
Middle Aged | 84 | 2020 | 10834 | 2.540 |
Why?
|
Depression | 17 | 2018 | 382 | 2.360 |
Why?
|
Female | 96 | 2020 | 18173 | 2.230 |
Why?
|
Health Status | 8 | 2019 | 368 | 2.200 |
Why?
|
Perimenopause | 7 | 2018 | 11 | 2.070 |
Why?
|
Sexual Behavior | 6 | 2018 | 97 | 2.010 |
Why?
|
Longitudinal Studies | 30 | 2020 | 721 | 2.010 |
Why?
|
Yoga | 5 | 2019 | 41 | 1.890 |
Why?
|
Humans | 101 | 2020 | 29123 | 1.790 |
Why?
|
Adult | 60 | 2020 | 8426 | 1.750 |
Why?
|
Ethnic Groups | 12 | 2019 | 440 | 1.710 |
Why?
|
Vasomotor System | 9 | 2020 | 15 | 1.660 |
Why?
|
Sexuality | 4 | 2017 | 9 | 1.500 |
Why?
|
Sweating | 10 | 2020 | 15 | 1.440 |
Why?
|
Premenopause | 7 | 2018 | 38 | 1.210 |
Why?
|
Aging | 9 | 2020 | 881 | 1.180 |
Why?
|
Exercise | 4 | 2020 | 592 | 1.180 |
Why?
|
Sickness Impact Profile | 4 | 2014 | 34 | 1.120 |
Why?
|
Stress, Psychological | 8 | 2018 | 208 | 1.100 |
Why?
|
Body Mass Index | 8 | 2020 | 865 | 1.080 |
Why?
|
Social Support | 7 | 2017 | 163 | 1.070 |
Why?
|
Aged | 29 | 2020 | 9492 | 1.040 |
Why?
|
Postmenopause | 8 | 2017 | 397 | 1.040 |
Why?
|
Attitude to Health | 6 | 2009 | 148 | 1.010 |
Why?
|
Psychometrics | 4 | 2015 | 129 | 0.900 |
Why?
|
United States | 32 | 2020 | 3632 | 0.900 |
Why?
|
Cross-Sectional Studies | 16 | 2020 | 1362 | 0.890 |
Why?
|
Spirituality | 3 | 2018 | 33 | 0.850 |
Why?
|
Anxiety | 9 | 2018 | 159 | 0.830 |
Why?
|
Multivariate Analysis | 11 | 2018 | 637 | 0.770 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2018 | 10 | 0.760 |
Why?
|
Colorectal Neoplasms | 3 | 2020 | 208 | 0.740 |
Why?
|
African Americans | 7 | 2017 | 1373 | 0.730 |
Why?
|
Risk Factors | 19 | 2020 | 3537 | 0.700 |
Why?
|
Patient Participation | 2 | 2012 | 62 | 0.690 |
Why?
|
Logistic Models | 11 | 2020 | 727 | 0.680 |
Why?
|
Age Factors | 11 | 2020 | 1108 | 0.680 |
Why?
|
Neoplasms | 4 | 2019 | 611 | 0.670 |
Why?
|
Patient Satisfaction | 2 | 2017 | 222 | 0.670 |
Why?
|
Time Factors | 11 | 2019 | 2001 | 0.650 |
Why?
|
Mental Health | 5 | 2020 | 104 | 0.630 |
Why?
|
Cohort Studies | 11 | 2020 | 1688 | 0.630 |
Why?
|
Breast | 1 | 2018 | 53 | 0.620 |
Why?
|
Socioeconomic Factors | 10 | 2018 | 391 | 0.620 |
Why?
|
Mammaplasty | 1 | 2017 | 27 | 0.620 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2017 | 9 | 0.600 |
Why?
|
Educational Status | 7 | 2019 | 164 | 0.590 |
Why?
|
Waist Circumference | 1 | 2017 | 89 | 0.580 |
Why?
|
Smoking | 6 | 2019 | 427 | 0.580 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 87 | 0.570 |
Why?
|
Mastectomy | 4 | 2017 | 59 | 0.560 |
Why?
|
Health Behavior | 2 | 2017 | 214 | 0.550 |
Why?
|
Prostatic Neoplasms | 3 | 2020 | 441 | 0.540 |
Why?
|
Models, Theoretical | 1 | 2016 | 126 | 0.530 |
Why?
|
Workplace | 1 | 2015 | 47 | 0.520 |
Why?
|
Cross-Cultural Comparison | 5 | 2016 | 24 | 0.520 |
Why?
|
Body Weight | 1 | 2017 | 290 | 0.520 |
Why?
|
Estradiol | 5 | 2018 | 118 | 0.520 |
Why?
|
Libido | 3 | 2015 | 3 | 0.510 |
Why?
|
Decision Making | 3 | 2012 | 180 | 0.450 |
Why?
|
Aged, 80 and over | 10 | 2020 | 3719 | 0.450 |
Why?
|
Follow-Up Studies | 9 | 2018 | 2109 | 0.440 |
Why?
|
Ovariectomy | 2 | 2017 | 147 | 0.430 |
Why?
|
Women | 2 | 2009 | 10 | 0.420 |
Why?
|
Health Surveys | 7 | 2009 | 191 | 0.400 |
Why?
|
Prospective Studies | 8 | 2020 | 2021 | 0.400 |
Why?
|
Estrogen Replacement Therapy | 5 | 2019 | 182 | 0.400 |
Why?
|
European Continental Ancestry Group | 10 | 2017 | 1131 | 0.380 |
Why?
|
Asian Americans | 6 | 2017 | 98 | 0.380 |
Why?
|
Health Status Indicators | 2 | 2015 | 67 | 0.370 |
Why?
|
Cardiovascular Diseases | 4 | 2020 | 1017 | 0.370 |
Why?
|
Hispanic Americans | 8 | 2017 | 904 | 0.350 |
Why?
|
Testosterone | 4 | 2018 | 47 | 0.350 |
Why?
|
Markov Chains | 2 | 2020 | 25 | 0.340 |
Why?
|
Hypnosis | 1 | 2008 | 3 | 0.340 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2008 | 35 | 0.330 |
Why?
|
Continental Population Groups | 4 | 2019 | 221 | 0.330 |
Why?
|
Dyspareunia | 3 | 2018 | 7 | 0.330 |
Why?
|
Prevalence | 8 | 2018 | 898 | 0.320 |
Why?
|
Follicle Stimulating Hormone | 3 | 2015 | 19 | 0.300 |
Why?
|
Treatment Outcome | 5 | 2017 | 3101 | 0.300 |
Why?
|
Pain | 3 | 2018 | 282 | 0.300 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 8 | 0.290 |
Why?
|
Mental Disorders | 1 | 2007 | 103 | 0.280 |
Why?
|
Life Change Events | 3 | 2013 | 21 | 0.280 |
Why?
|
Vulvar Diseases | 1 | 2006 | 2 | 0.280 |
Why?
|
Pelvic Pain | 1 | 2006 | 18 | 0.280 |
Why?
|
Informed Consent | 1 | 2006 | 51 | 0.270 |
Why?
|
Pilot Projects | 3 | 2016 | 469 | 0.270 |
Why?
|
Menopause, Premature | 3 | 2018 | 8 | 0.260 |
Why?
|
Cognition | 5 | 2019 | 526 | 0.250 |
Why?
|
Mammography | 1 | 2004 | 37 | 0.250 |
Why?
|
Emotions | 2 | 2018 | 48 | 0.250 |
Why?
|
Video Recording | 1 | 2004 | 52 | 0.250 |
Why?
|
Cultural Diversity | 1 | 2004 | 19 | 0.250 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 298 | 0.240 |
Why?
|
Self Concept | 1 | 2004 | 41 | 0.240 |
Why?
|
Interpersonal Relations | 3 | 2013 | 54 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 2 | 2008 | 154 | 0.230 |
Why?
|
Marital Status | 4 | 2018 | 20 | 0.230 |
Why?
|
Male | 11 | 2020 | 17815 | 0.230 |
Why?
|
Menarche | 2 | 2020 | 4 | 0.230 |
Why?
|
Japan | 4 | 2017 | 15 | 0.220 |
Why?
|
Masturbation | 2 | 2015 | 2 | 0.220 |
Why?
|
China | 4 | 2017 | 44 | 0.220 |
Why?
|
Patient Education as Topic | 2 | 2020 | 251 | 0.210 |
Why?
|
Life Style | 7 | 2016 | 364 | 0.210 |
Why?
|
Cognition Disorders | 2 | 2019 | 390 | 0.210 |
Why?
|
Registries | 2 | 2013 | 278 | 0.200 |
Why?
|
Severity of Illness Index | 4 | 2014 | 863 | 0.200 |
Why?
|
Climacteric | 3 | 2007 | 6 | 0.200 |
Why?
|
Role | 2 | 2012 | 5 | 0.200 |
Why?
|
Dehydroepiandrosterone Sulfate | 3 | 2018 | 8 | 0.200 |
Why?
|
Prognosis | 2 | 2020 | 1362 | 0.190 |
Why?
|
Chronic Disease | 3 | 2016 | 370 | 0.190 |
Why?
|
Analysis of Variance | 2 | 2018 | 454 | 0.190 |
Why?
|
Vaginal Diseases | 2 | 2018 | 6 | 0.190 |
Why?
|
Hysterectomy | 2 | 2018 | 37 | 0.190 |
Why?
|
Biomedical Research | 2 | 2013 | 153 | 0.190 |
Why?
|
Karnofsky Performance Status | 1 | 2020 | 10 | 0.190 |
Why?
|
Psychology | 2 | 2013 | 22 | 0.190 |
Why?
|
Case-Control Studies | 2 | 2020 | 859 | 0.190 |
Why?
|
Activities of Daily Living | 2 | 2013 | 240 | 0.180 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2020 | 45 | 0.180 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2015 | 92 | 0.180 |
Why?
|
Incidence | 5 | 2020 | 1119 | 0.180 |
Why?
|
Peripheral Nerves | 1 | 2020 | 59 | 0.180 |
Why?
|
Needs Assessment | 1 | 2020 | 66 | 0.180 |
Why?
|
Patient Compliance | 2 | 2016 | 208 | 0.180 |
Why?
|
Australia | 4 | 2020 | 66 | 0.180 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 66 | 0.180 |
Why?
|
Regression Analysis | 2 | 2012 | 274 | 0.170 |
Why?
|
Cranial Irradiation | 1 | 2019 | 84 | 0.170 |
Why?
|
Premenstrual Syndrome | 1 | 2018 | 3 | 0.170 |
Why?
|
Ovarian Diseases | 1 | 2018 | 8 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 464 | 0.170 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 546 | 0.170 |
Why?
|
Affect | 2 | 2012 | 63 | 0.170 |
Why?
|
Demography | 1 | 2018 | 104 | 0.170 |
Why?
|
Accidental Falls | 1 | 2020 | 204 | 0.170 |
Why?
|
Urinary Incontinence | 1 | 2018 | 45 | 0.160 |
Why?
|
Beauty | 1 | 2017 | 4 | 0.160 |
Why?
|
Pain Measurement | 3 | 2016 | 364 | 0.160 |
Why?
|
Odds Ratio | 4 | 2020 | 447 | 0.160 |
Why?
|
Sleep | 2 | 2016 | 87 | 0.160 |
Why?
|
Smoking Cessation | 1 | 2018 | 118 | 0.150 |
Why?
|
Proportional Hazards Models | 4 | 2020 | 709 | 0.140 |
Why?
|
Hormone Replacement Therapy | 3 | 2018 | 86 | 0.140 |
Why?
|
Disease Progression | 1 | 2018 | 572 | 0.140 |
Why?
|
Models, Biological | 1 | 2018 | 373 | 0.140 |
Why?
|
Probability | 2 | 2007 | 150 | 0.140 |
Why?
|
Social Perception | 1 | 2015 | 21 | 0.140 |
Why?
|
Obesity | 2 | 2020 | 1063 | 0.140 |
Why?
|
Cost of Illness | 1 | 2015 | 63 | 0.130 |
Why?
|
Menstruation | 1 | 2015 | 4 | 0.130 |
Why?
|
Hyperhidrosis | 2 | 2020 | 5 | 0.130 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2016 | 41 | 0.130 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2015 | 14 | 0.130 |
Why?
|
Data Collection | 2 | 2006 | 163 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2007 | 436 | 0.130 |
Why?
|
Social Adjustment | 1 | 2014 | 8 | 0.130 |
Why?
|
Cytokines | 1 | 2016 | 243 | 0.130 |
Why?
|
Linear Models | 2 | 2013 | 426 | 0.130 |
Why?
|
Combined Modality Therapy | 2 | 2007 | 525 | 0.120 |
Why?
|
Depressive Disorder | 2 | 2012 | 74 | 0.120 |
Why?
|
Alcohol Drinking | 1 | 2017 | 244 | 0.120 |
Why?
|
Behavioral Sciences | 1 | 2013 | 1 | 0.120 |
Why?
|
Asian Continental Ancestry Group | 3 | 2016 | 110 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 401 | 0.120 |
Why?
|
Pain, Postoperative | 1 | 2016 | 174 | 0.120 |
Why?
|
Information Dissemination | 1 | 2013 | 42 | 0.110 |
Why?
|
Leukemia | 1 | 2013 | 36 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 368 | 0.110 |
Why?
|
Lymphoma | 1 | 2013 | 36 | 0.110 |
Why?
|
Anthracyclines | 1 | 2013 | 51 | 0.110 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 62 | 0.110 |
Why?
|
Syndrome | 2 | 2018 | 66 | 0.110 |
Why?
|
Patient Preference | 1 | 2012 | 38 | 0.110 |
Why?
|
Databases, Factual | 1 | 2013 | 332 | 0.110 |
Why?
|
Risk Assessment | 3 | 2019 | 1306 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2012 | 176 | 0.100 |
Why?
|
Age of Onset | 2 | 2018 | 95 | 0.100 |
Why?
|
Reward | 1 | 2012 | 63 | 0.100 |
Why?
|
African Continental Ancestry Group | 3 | 2016 | 350 | 0.100 |
Why?
|
Neuropsychological Tests | 2 | 2009 | 379 | 0.100 |
Why?
|
Population Surveillance | 2 | 2008 | 119 | 0.090 |
Why?
|
Endocrine Glands | 1 | 2010 | 2 | 0.090 |
Why?
|
Computational Biology | 1 | 2010 | 86 | 0.090 |
Why?
|
Public Health | 1 | 2010 | 73 | 0.090 |
Why?
|
Myocardial Infarction | 2 | 2020 | 413 | 0.090 |
Why?
|
Mental Processes | 1 | 2009 | 17 | 0.090 |
Why?
|
Young Adult | 2 | 2013 | 2402 | 0.090 |
Why?
|
Social Behavior | 1 | 2009 | 67 | 0.090 |
Why?
|
Placebo Effect | 1 | 2008 | 14 | 0.080 |
Why?
|
Research Design | 2 | 2010 | 286 | 0.080 |
Why?
|
Estrogens | 1 | 2010 | 162 | 0.080 |
Why?
|
Affective Symptoms | 1 | 2008 | 16 | 0.080 |
Why?
|
Europe | 2 | 2018 | 77 | 0.080 |
Why?
|
Palliative Care | 1 | 2008 | 47 | 0.080 |
Why?
|
North Carolina | 1 | 2012 | 1423 | 0.080 |
Why?
|
Risk | 2 | 2020 | 289 | 0.080 |
Why?
|
Survival Rate | 2 | 2007 | 795 | 0.080 |
Why?
|
Retrospective Studies | 2 | 2012 | 3112 | 0.080 |
Why?
|
New Hampshire | 1 | 2006 | 5 | 0.070 |
Why?
|
Boston | 1 | 2006 | 16 | 0.070 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 51 | 0.070 |
Why?
|
Biopsy, Needle | 1 | 2007 | 89 | 0.070 |
Why?
|
Travel | 1 | 2006 | 15 | 0.070 |
Why?
|
New Jersey | 1 | 2006 | 10 | 0.070 |
Why?
|
Happiness | 1 | 2005 | 3 | 0.070 |
Why?
|
Shock, Cardiogenic | 1 | 2005 | 7 | 0.070 |
Why?
|
Contraception | 1 | 2005 | 12 | 0.070 |
Why?
|
Perception | 1 | 2006 | 92 | 0.070 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 37 | 0.070 |
Why?
|
Florida | 1 | 2005 | 33 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2007 | 519 | 0.070 |
Why?
|
Vagina | 1 | 2005 | 47 | 0.070 |
Why?
|
Pamphlets | 1 | 2004 | 5 | 0.060 |
Why?
|
Stroke | 2 | 2020 | 548 | 0.060 |
Why?
|
Patient Selection | 1 | 2006 | 257 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2006 | 169 | 0.060 |
Why?
|
Age Distribution | 1 | 2004 | 198 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 337 | 0.060 |
Why?
|
Adolescent | 2 | 2016 | 3255 | 0.060 |
Why?
|
Sex Factors | 1 | 2006 | 631 | 0.060 |
Why?
|
Education | 1 | 2003 | 30 | 0.060 |
Why?
|
Mass Screening | 1 | 2004 | 223 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 293 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2013 | 14 | 0.050 |
Why?
|
Comorbidity | 2 | 2018 | 540 | 0.050 |
Why?
|
Child | 2 | 2020 | 2219 | 0.050 |
Why?
|
Angina Pectoris | 1 | 2020 | 19 | 0.050 |
Why?
|
Appalachian Region | 1 | 2020 | 16 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2015 | 726 | 0.050 |
Why?
|
Vulnerable Populations | 1 | 2020 | 25 | 0.050 |
Why?
|
Recurrence | 1 | 2020 | 235 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 98 | 0.040 |
Why?
|
Fatigue | 1 | 2019 | 68 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2020 | 134 | 0.040 |
Why?
|
Coitus | 1 | 2018 | 2 | 0.040 |
Why?
|
Rural Population | 1 | 2020 | 246 | 0.040 |
Why?
|
Coronary Disease | 1 | 2019 | 200 | 0.040 |
Why?
|
Thinness | 1 | 2018 | 31 | 0.040 |
Why?
|
Memory | 2 | 2010 | 187 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2018 | 103 | 0.040 |
Why?
|
Middle East | 1 | 2016 | 5 | 0.040 |
Why?
|
Latin America | 1 | 2016 | 9 | 0.040 |
Why?
|
Genital Neoplasms, Female | 1 | 2016 | 15 | 0.030 |
Why?
|
Overweight | 1 | 2018 | 256 | 0.030 |
Why?
|
Patient Care Management | 1 | 2016 | 17 | 0.030 |
Why?
|
Meditation | 1 | 2016 | 22 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 70 | 0.030 |
Why?
|
Checklist | 1 | 2015 | 35 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2015 | 128 | 0.030 |
Why?
|
Computer Security | 1 | 2013 | 6 | 0.030 |
Why?
|
Medical Informatics | 1 | 2013 | 18 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2013 | 24 | 0.030 |
Why?
|
Irritable Mood | 1 | 2013 | 3 | 0.030 |
Why?
|
Troponin I | 1 | 2013 | 17 | 0.030 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 20 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2013 | 5 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 57 | 0.030 |
Why?
|
International Cooperation | 1 | 2013 | 25 | 0.030 |
Why?
|
Fear | 1 | 2013 | 44 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2013 | 30 | 0.030 |
Why?
|
Tamoxifen | 1 | 2012 | 48 | 0.030 |
Why?
|
Internet | 1 | 2013 | 156 | 0.030 |
Why?
|
Health Policy | 1 | 2013 | 80 | 0.030 |
Why?
|
Brain | 1 | 2019 | 930 | 0.030 |
Why?
|
Ventricular Function, Left | 1 | 2013 | 195 | 0.030 |
Why?
|
Mothers | 1 | 2012 | 79 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 787 | 0.020 |
Why?
|
Stroke Volume | 1 | 2013 | 279 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 24 | 0.020 |
Why?
|
Psychological Tests | 1 | 2010 | 33 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2010 | 19 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2010 | 171 | 0.020 |
Why?
|
Sleep Disorders, Intrinsic | 1 | 2008 | 1 | 0.020 |
Why?
|
Selection Bias | 1 | 2008 | 12 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 1219 | 0.020 |
Why?
|
Personality Inventory | 1 | 2007 | 18 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 532 | 0.020 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2005 | 6 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2005 | 42 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2005 | 59 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 100 | 0.020 |
Why?
|
Recovery of Function | 1 | 2005 | 190 | 0.020 |
Why?
|
Survival Analysis | 1 | 2005 | 440 | 0.020 |
Why?
|